Kevin Winthrop, from Oregon Health & Science University in Portland, USA, discusses why patients with rheumatic diseases may be vulnerable to COVID-19 and how different treatments may affect the risk for infection and prognosis of the disease. <a href="http://bit.ly/Winthrop-COVID-19-podcast">Find more on Medicine Matters rheumatology</a>

Kevin Winthrop, from Oregon Health & Science University in Portland, USA, discusses why patients with rheumatic diseases may be vulnerable to COVID-19 and how different treatments may affect the risk for infection and prognosis of the disease. Find more on Medicine Matters rheumatology

Kevin Winthrop, from Oregon Health &amp; Science University in Portland, USA, discusses why patients with rheumatic diseases may be vulnerable to COVID-19 and how different treatments may affect the risk for infection and prognosis of the disease. <a href="http://bit.ly/Winthrop-COVID-19-podcast" rel="noopener noreferrer">Find more on Medicine Matters rheumatology</a>

COVID-19 in people with rheumatic diseases (with Kevin Winthrop)

Interviews with clinical experts, discussing key issues in rheumatology.

Share COVID-19 in people with rheumatic diseases (with Kevin Winthrop)

Sign up to save your podcasts

COVID-19 in people with rheumatic diseases (with Kevin Winthrop)

COVID-19 in people with rheumatic diseases (with Kevin Winthrop)